Roughly, 3 to 8% of women suffer from premenstrual dysphoric disorder (PMDD), a disorder that causes anxiety, depression, and mood swings during the menstruation cycle. PMDD appears to increase serotonin transporter density from the preovulation phase to the premenstrual cycle phase. The findings could aid in the development of new treatments for PMDD.
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects one in twenty women. PMDD can have a debilitating impact on the lives of sufferers. Researchers investigate PMDD and evaluate treatment options for sufferers.
A new study reveals that 34% of people with premenstrual dysphoric disorder (PMDD) have attempted suicide. Researchers say PMDD is an independent contributor to suicidal thoughts and behaviors.
Researchers report dysregulated expression of a gene complex could explain why PMDD is a disorder of cellular response to progesterone and estrogen.
As estrogen levels rise in women, the volume of the hippocampus increases, a new study reports.